Novavax | NVAX - DETTE





DETTE Changement Date
Adma Biologics USD 204.41M 121.28M 2026-03
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 33.92B 4.3B 2026-03
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Cassava Sciences USD 0 0 2024-12
Geron USD 121.99M 76K 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
MannKind USD 367.44M 247.53M 2025-12
Merck USD 49.34B 7.97B 2025-12
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.31B 571M 2025-12
Novartis USD 47B 14.98B 2026-03
Novavax USD 233.31M 4.23M 2024-09
Pfizer USD 63.73B 231M 2026-03
Sanofi EUR 20.33B 1.43B 2025-12
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
TG Therapeutics USD 253.71M 8.37M 2025-12